Loading clinical trials...
Loading clinical trials...
Tumour Cell Response to Acute Aerobic Exercise in Breast Cancer Survivors: Modulatory Effects of Exercise Type and Intensity (TCReX) No: RSU/LSPA-PA-2024/1-0004 is Financed by the Investment of the European Union Recovery and Resilience Facility and the State Budget Within the Project "RSU Internal and RSU With LASE External Consolidation" No. 5.2.1.1.i.0/2/24/I/CFLA/005.
Conditions
Interventions
High intensity continuous exercise
Moderate intensity continuous exercise
Locations
1
Latvia
Laboratory of Sports and Nutrition Research
Riga, Dzirciema Street 16, Latvia
Start Date
April 1, 2024
Primary Completion Date
March 31, 2026
Completion Date
March 31, 2026
Last Updated
February 27, 2026
NCT07379918
NCT06478589
NCT06729684
NCT06645119
NCT06073717
NCT04262180
Lead Sponsor
Riga Stradins University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions